Citigroup Inc INHIBIKASE THERAPEUTICS INC Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
Number of Shares
20,393
Previous 25,765
20.85%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%